Oocyte developmental competence and embryo development: impact of lifestyle and environmental risk factors
Abstract
Oocyte development is the end result of a sophisticated biological process that is hormonally regulated and produced by highly specialized cellular lines that differentiate in early embryo/fetal development. Embryo development is initially regulated by maternal transcripts until replaced by embryonic genomic expression. Then, an assortment of hormones and local environmental factors in various concentrations along the reproductive tract (e.g. fallopian tube, endometrial lining) provide the protection, nutrients and means of communication for the embryo to implant and develop. Both oocytes and embryos are susceptible to environmental, occupational and lifestyle exposures that can exert direct toxic effects and disrupt hormones. While some exposures may produce reversible changes, others, especially those damaging germinal cells in utero or during prepuberty, may result in permanent sequelae that continue in future generations. This article reviews the main factors that affect female fertility and their possible influence on human reproduction. Some lifestyles, xeno-oestrogens and heavy metals are already known to compromise female reproductive function. Nonetheless, many questions remain and little is known about the effect of many other factors on female fertility.
Keywords: embryo, environmental exposures, lifestyle, oocyte, xeno-oestrogens
Alex C Varghese has been an active embryologist and researcher on IVF since 1997 and received his PhD in 2005 from University of Calcutta, India. In 2008, after his post-doctoral tenure at Centre for Reproductive Medicine, Cleveland Clinic, Ohio, USA, he became scientific director and chief embryologist at Fertility Clinic and IVF Department, AMRI Hospital. Alex founded lifeinvitro.com, a knowledge-sharing platform. His particular interests are molecular causes and prevention of male infertility, genomics and metabolomics in embryology and cryotolerence of reproductive cells. He is Secretary of Institute of Reproductive Health and Toxicology and Vice-President of Academy of Clinical Embryologists, India.
PII: S1472-6483(10)00729-7
doi:10.1016/j.rbmo.2010.11.009
© 2010 Reproductive Healthcare Ltd. Published by Elsevier Inc All rights reserved.
